Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022 Shoji KimuraKeisuke ShigetaYuji Miura Special Article 28 March 2024 Pages: 559 - 563
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial Han Byul KangSung Hwan KimJong Hoon Lee Original Article 26 March 2024 Pages: 620 - 628
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022 Yukinori OzakiTakamichi YokoeToshimi Takano Special Article 25 March 2024 Pages: 551 - 558
PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site João Neif Antonio JuniorDaniel D.’Almeida PretoFlavio Mavignier Cárcano Original Article Open access 25 March 2024
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study Chung Ryul OhHyehyun JeongJin-Hee Ahn Original Article 25 March 2024
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan Shin MuraiHiroaki NozawaSoichiro Ishihara Original Article Open access 25 March 2024
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice Della VargheseGiovanna I. CruzHenry G. Kaplan Original Article Open access 25 March 2024
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy Zhimin GaoYubin PangHailong Li Original Article Open access 22 March 2024 Pages: 592 - 601
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022 Keita UchinoShingo TamuraYuji Miura Special Article 22 March 2024 Pages: 545 - 550
Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors Yosuke KanoHiroshi IchikawaToshifumi Wakai Original Article 21 March 2024
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology Tomoya MaedaYuho NajimaShingo Yano Special Article Open access 18 March 2024 Pages: 535 - 544
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2 Yoshinori KikuchiHideaki ShimadaHiroyuki Takahashi Special Article 17 March 2024 Pages: 512 - 534
Salivary gland-type cancers: cross-organ demographics of a rare cancer Aika TanzawaKengo SaitoYuichi Takiguchi Original Article Open access 16 March 2024
An approach for improvement of the accuracy of cancer gene panel testing Kiyomi ImotoHiroyuki YamamotoYu Sunakawa Original Article 12 March 2024 Pages: 571 - 581
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab Masaki HashimotoWataru FukuokayaTakahiro Kimura Original Article 02 March 2024 Pages: 612 - 619
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis Mashio NakamuraMasato SakonMasataka Ikeda Original Article Open access 02 March 2024 Pages: 407 - 416
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study Rikiya TaokaMasaki KamadaMikio Sugimoto Original Article 28 February 2024 Pages: 602 - 611
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry Ryoko RikitakeYu MizushimaAkira Kawai Cancer Statistics Open access 27 February 2024 Pages: 564 - 570
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer Yang LiJun QinXing Sun Original Article 27 February 2024 Pages: 427 - 441
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance Sena YamamotoChiharu KondohHarue Arao Original Article Open access 24 February 2024 Pages: 417 - 426
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression Zijun GuoLin Guo Original Article 21 February 2024 Pages: 442 - 455
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study Yuki KatsuyaTatsuya YoshidaNoboru Yamamoto Original Article Open access 21 February 2024 Pages: 386 - 397
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021 Hidekatsu NakaiTakahiro HigashiNoriomi Matsumura Cancer Statistics 21 February 2024 Pages: 363 - 371
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan Junji FuruseFumihiko OsugiToshimitsu Endo Original Article Open access 14 February 2024 Pages: 456 - 463
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study Shigeki KataokaYoshitaka NishikawaManabu Muto Original Article 14 February 2024 Pages: 398 - 406
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022 Eiki IchiharaNobuaki OchiToshio Kubo Special Article 14 February 2024 Pages: 355 - 362
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data Hiroki IshiharaKenji OmaeToshio Takagi Original Article 12 February 2024 Pages: 473 - 480
Announcement: Third Joint Committee Report on Diabetes and Cancer Editorial Note 10 February 2024 Pages: 354 - 354
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy Honami SatoTakahiro KobayashiNaoto Takahashi Original Article Open access 09 February 2024 Pages: 481 - 492
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy Toru KannoGo KoboriHitoshi Yamada Original Article 06 February 2024 Pages: 464 - 472
Skeletal muscle status and survival among patients with advanced biliary tract cancer Shinya TakaokaTsuyoshi HamadaMitsuhiro Fujishiro Original Article Open access 06 February 2024 Pages: 297 - 308
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system Kotaro NomuraKeiju AokageMasahiro Tsuboi Original Article 06 February 2024 Pages: 248 - 257
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study Hasan Çağrı YıldırımYasin KutluSercan Aksoy Original Article 04 February 2024 Pages: 258 - 265
Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer Keigo YokoiAkiko WatanabeTakeshi Naitoh Original Article 29 January 2024 Pages: 276 - 285
Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements Masaru TakenakaKoji KurodaFumihiro Tanaka Invited Review Article 28 January 2024
Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction Tomoya EmoriMasahiro ItonagaMasayuki Kitano Original Article 27 January 2024 Pages: 286 - 296
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan Shuhei SuzukiYoshiyuki NagumoHiroyuki Nishiyama Original Article 24 January 2024 Pages: 318 - 324
Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC Norifumi HarimotoMariko TsukagoshiKen Shirabe Original Article 16 January 2024 Pages: 195 - 204
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902) Tomono KawaseHiroshi ImamuraTaroh Satoh Original Article 16 January 2024 Pages: 134 - 141
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer Kazuhiro NishikawaYutaka KimuraHiroshi Imamura Original Article 16 January 2024 Pages: 266 - 275
Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis Tomohiro MatsumotoRika YoshimatsuTakuji Yamagami Original Article 13 January 2024 Pages: 372 - 385
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer Rihito AizawaHaruo InokuchiTakashi Mizowaki Original Article 08 January 2024 Pages: 325 - 332
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing Kazushige WakudaMeiko MoritaToshiaki Takahashi Original Article 06 January 2024 Pages: 96 - 102
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability Tsuyoshi YamashitaTakahiro ItohHideki Satoh Original Article Open access 05 January 2024 Pages: 222 - 231
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice Dag Rune StormoenUlla Nordström JoensenHelle Pappot Original Article Open access 05 January 2024 Pages: 309 - 317
FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells Hongye YaoJuan LiJun Yin Original Article 03 January 2024 Pages: 333 - 344
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer Atsuto MouriKyoichi KairaHiroshi Kagamu Original Article 31 December 2023 Pages: 124 - 133
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma Hideki GotoSatoshi ItoKoji Izutsu Original Article Open access 29 December 2023 Pages: 232 - 240
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan Koichi YasudaYusuke UchinamiHidefumi Aoyama Original Article 29 December 2023 Pages: 241 - 247
Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan Nobuko NakamuraShinji HasebeYoshihiro Yakushijin Original Article 28 December 2023 Pages: 345 - 353